ASX - Delayed Quote AUD
Genetic Signatures Limited (GSS.AX)
At close: 3:05 PM GMT+11
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
9,766.0000
9,766.0000
21,360.0000
35,421.0000
28,284.0000
Cost of Revenue
5,458.0000
5,458.0000
7,996.0000
11,989.0000
9,804.0000
Gross Profit
4,308.0000
4,308.0000
13,364.0000
23,432.0000
18,480.0000
Operating Expense
26,641.0000
26,641.0000
28,110.0000
20,567.0000
17,123.0000
Operating Income
-22,333.0000
-22,333.0000
-14,746.0000
2,865.0000
1,357.0000
Net Non Operating Interest Income Expense
469.0000
469.0000
542.0000
113.0000
170.0000
Other Income Expense
4,002.0000
4,002.0000
152.0000
85.0000
229.0000
Pretax Income
-17,862.0000
-17,862.0000
-14,052.0000
3,063.0000
1,756.0000
Net Income Common Stockholders
-17,862.0000
-17,862.0000
-14,052.0000
3,063.0000
1,756.0000
Basic EPS
-0.11
--
-0.10
0.02
0.01
Diluted EPS
-0.11
--
-0.10
0.02
0.01
Basic Average Shares
165,264.4020
--
146,811.3780
146,506.9140
146,199.1330
Diluted Average Shares
165,264.4020
--
146,811.3780
148,619.6370
148,576.7300
Net Income from Continuing & Discontinued Operation
-17,862.0000
-17,862.0000
-14,052.0000
3,063.0000
1,756.0000
Normalized Income
-17,862.0000
-17,862.0000
-14,052.0000
3,063.0000
1,756.0000
Interest Income
504.0000
504.0000
543.0000
132.0000
206.0000
Interest Expense
33.0000
--
1.0000
19.0000
36.0000
Net Interest Income
469.0000
469.0000
542.0000
113.0000
170.0000
EBIT
-22,333.0000
-22,333.0000
-14,051.0000
3,082.0000
1,792.0000
EBITDA
-20,338.0000
-20,338.0000
-12,525.0000
4,698.0000
3,217.0000
Reconciled Cost of Revenue
5,458.0000
5,458.0000
7,996.0000
11,989.0000
9,804.0000
Reconciled Depreciation
1,995.0000
1,995.0000
1,526.0000
1,616.0000
1,425.0000
Net Income from Continuing Operation Net Minority Interest
-17,862.0000
-17,862.0000
-14,052.0000
3,063.0000
1,756.0000
Normalized EBITDA
-20,338.0000
-20,338.0000
-12,525.0000
4,698.0000
3,217.0000
6/30/2021 - 3/30/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CAJ.AX Capitol Health Limited
0.3850
+1.32%
MAP.AX Microba Life Sciences Limited
0.1650
0.00%
BDX.AX BCAL Diagnostics Limited
0.1100
+4.76%
GTG.AX Genetic Technologies Limited
0.0390
0.00%
LDX.AX Lumos Diagnostics Holdings Limited
0.0300
-6.25%
IIQ.AX INOVIQ Ltd
0.4750
+7.95%
IDX.AX Integral Diagnostics Limited
2.9700
-3.57%
ACL.AX Australian Clinical Labs Limited
3.4000
-0.58%
IBX.AX Imagion Biosystems Limited
0.0420
-12.50%
MVF.AX Monash IVF Group Limited
1.1150
-1.33%